Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

Supreme Court temporarily extends access to abortion pill

The court has given itself until Friday to rule on whether to allow restrictions to take effect on mifepristone as legal challenges to its FDA approval continue.

Chicago Sun-Times

Generic abortion pill manufacturer sues FDA in effort to preserve access

GenBioPro, which makes a generic form of mifepristone, is suing the FDA seeking to preserve access to the drug amidst ongoing federal litigation.

WEKU

Trade unions to urge Labour to make manifesto commitment to devolving drug law

TRADE Unions have agreed to urge Labour to include a commitment to devolve drug powers to Scotland in their next General Election manifesto.

The National (Scotland)

From analysis to the latest developments in health,
read the most diverse news in one place.

The drug company that prospered without creating any drugs

The new drug looked so promising — except for that one warning sign.

Tribune News Service

Abortion foes urge Supreme Court to curb pill on eve of deadline

Abortion opponents urged the U.S. Supreme Court to allow new restrictions on a widely used pill to end pregnancy, presenting the justices with a stark choice on one of the country’s most divisive issues.

Tribune News Service

Why Insiders Are Aggressively Buying This Under $1 Stock

While insiders are showing significant interest in penny stock Processa Pharmaceuticals (PCSA), the stock has witnessed a weak momentum over the past year. Let’s take a look at its key metrics to understand if there is any hope for sustainable share price appreciation. Read on.

StockNews.com

Anti-abortion groups urge US top court to restrict abortion pill

Groups push the US Supreme Court to reject Biden administration request to halt a Texas ruling limiting access to pill.

Al Jazeera

Read news from The Economist, FT, and more,
with one subscription

Abortion foes urge justices to allow limits on abortion drug

Lawyers for anti-abortion doctors are urging the Supreme Court to allow restrictions to take effect on a drug used in the most common method of abortion in the United States, while a lawsuit continues

The Independent UK

Tesco to close eight in-store pharmacies this year as part of huge shake-up

Tesco announced in January that was to introduce a raft of changes to the business in order to “remain focused and competitive in a fast-changing market”

Daily Mirror

Conservatives love judicial activism – as long as the law is moved in their favor

Brazen judicial overreach to curb abortion access proves the right wing will abandon their principles to get their way

The Guardian - US

Supreme Court blocks lower court rulings restricting abortion pills

The court's decision comes less than a year after it overturned Roe v. Wade, arguing it did not have the power to create abortion policy.

Axios

Biden administration asks US supreme court to halt abortion pill restrictions

Limits slated to go into effect at 12.01am Saturday following lower court’s order revoking the FDA’s approval of mifepristone

The Guardian - US

DOJ, drugmaker ask SCOTUS to intervene in abortion drug case

WASHINGTON — The Justice Department and a pharmaceutical company on Friday asked the Supreme Court to intervene in the court fight over a commonly used abortion drug in order to keep a court ruling restricting availability of the drug from taking effect this weekend.

Tribune News Service

Abortion pill could be unavailable for months without Supreme Court action-U.S. DOJ

New court-imposed restrictions on the abortion pill mifepristone could cut off access to the drug entirely for months, the Biden administration and the drug's distributor, Danco Laboratories, said in petitions asking the U.S. Supreme Court to lift the curbs.

Reuters

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

Commentary: Abortion pill ruling means more painful, later terminations

The conservative 5th Circuit has blocked part of a Texas judge’s decision to pull abortion drug mifepristone off the market, but leaves in place onerous and outdated restrictions that the Food and Drug Administration determined in 2016 were medically unnecessary.

Los Angeles Times

Abortion’s new battleground: Mifepristone’s effect on women’s mental health

At the heart of the latest battle over abortion access is a federal judge’s ruling that cites concern about the mental health of women who choose to end their pregnancies.

The Independent UK

Court preserves access to abortion drug, tightens rules

A federal appeals court has preserved access to an abortion drug for now but under tighter rules that would allow the drug only to be dispensed up to seven weeks, not 10, and not by mail

The Independent UK

Pharmaceutical executives challenge Texas court’s abortion pill ruling

Gilead Sciences and Pfizer join amicus brief

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - US

US drug tsar warns xylazine tranquilizer mixed with fentanyl is ‘emerging threat’

Dr Rahul Gupta says drug has become increasingly common nationwide and is particularly dangerous when mixed with opioid fentanyl

The Independent UK

US names veterinary drug, fentanyl mixture 'emerging threat'

The U.S. Office of National Drug Control Policy is designating the tranquilizer xylazine when mixed with fentanyl as an emerging threat

Tribune News Service

Lisa Jarvis: Abortion pill ruling threatens pharmaceutical innovation

A Texas federal judge’s ruling to remove the 23-year-old drug mifepristone from the market not only threatens abortion access in the U.S. — it’s also an appalling sideswipe at the Food and Drug Administration’s authority and expertise.

Tribune News Service

Abortion drug rulings spur drugmaker worries about precedent

WASHINGTON — Experts worry two recent rulings challenging the Food and Drug Administration’s regulation of a drug used in medication abortions threaten to complicate the agency’s oversight and the pipeline for future research and drug approvals.

Salon

GOP sadism proudly on display

The abortion pill decision proves, yet again, that there's nothing "pro-life" about Republicans

Tribune News Service

Legal fight over abortion drug could quickly hit Supreme Court

WASHINGTON — The Justice Department and several Democrat-led states took steps Monday to preserve access to a commonly used medication abortion drug after dueling federal court rulings about its availability.

StockNews.com

2 Biotech Stocks That Are Screaming “SELL ME!”

The biotech sector is witnessing the headwinds from the banking crisis, layoffs, and the Inflation Reduction Act. So, fundamentally weak biotech stocks Ginkgo Bioworks Holdings (DNA) and Novavax (NVAX) might be best avoided. Read on.

1 … 54 55 56 57

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Scottish Government

the Justice Department

Food and Drug Administration

338 stories

APA

258 stories

the Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.